Anti-HCV Next (K262156): 510(k) cleared for Abbott Laboratories

Anti-HCV Next (K262156): 510(k) cleared for Abbott Laboratories (Illinois): 510(k) cleared for Abbott Laboratories. Its amount of 89 is below the median of 138 (29th percentile). Dated 42 days ago, it serves as a historical benchmark. Score 36/100. As of 2026-11-03, from U.S. FDA openFDA (510(k) clearances and device enforcement reports).

Data as of · Compiled by Zalwin from U.S. FDA openFDA (510(k) clearances and device enforcement reports)

amount: 89 · 29th percentile of 414 FDAPulse records · 0.6x the median

Free preview: all 14 published fields of this record are shown below. Locked: 56 related IL FDAPulse records and the 5-column CSV export.

FieldValue
Record510(k) clearance
510(k) numberK262156
DeviceAnti-HCV Next
ApplicantAbbott Laboratories
Specialty / panelMicrobiology
Product codeMZO
Device class2
Clearance typeTraditional
DecisionSubstantially Equivalent
Received2026-06-26
Decision date2026-09-23
Review time (days)89
Third-party reviewNo
Applicant locationAbbott Park, IL, US
amount percentile29th of 414 (median 138, 0.6x median)
Peer records CSV (57 IL records) 🔒 Click to unlock →
CRM-ready export with official source URLs 🔒 Click to unlock →

View the official record

Markdown version

Watch Anti-HCV Next (K262156): 510(k) cleared for Abbott Laboratories

Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.

Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.

Free first: a 10-record sample of IL records

See the real columns before you buy. One confirmation email, nothing else unless you opt in.

Unlock Anti-HCV Next (K262156): 510(k) cleared for Abbott Laboratories + all 57 IL records (CSV)

Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Record · Specialty · Date · Review days · Recall class · official source URL

  • Source agency: U.S. FDA openFDA (510(k) clearances and device enforcement reports)
  • Record date: 2026-09-23
  • Data refreshed: 2026-11-03
  • Refunds on request within 14 days

Search all IL records free →

Top FDAPulse records (IL first): SmartIPL_NI System (K241973) · Hyperdrive 35 Guidewire (K253146) · Tempus ECG-MR (K254297) · Ecomed Disposable Administration Sets (K254123) · TumorSight Risk (K260023) · Browse all by state and category →

LIVE PUBLIC DATA Source: U.S. FDA openFDA (510(k) clearances and device enforcement reports) · Last refreshed: Tue, 03 Nov 2026 18:05:14 GMT

Is this your business? Add a "Listed on Zalwin" badge to your site

Paste this snippet into your website. It links to this public record; nothing is tracked on your site.

Listed on Zalwin badge preview

Peer benchmark and outreach value: Anti-HCV Next (K262156): 510(k) cleared for Abbott Laboratories and 57 Illinois peers

  • Illinois FDAPulse records like this one: 57
  • Anti-HCV Next (K262156): 510(k) cleared for Abbott Laboratories's amount: 29th percentile of 414 records
  • Timing: Low: older than 30 days
  • Estimated pipeline if you contact every Illinois peer: $11,400 (peers × rate × deal size; an estimate from your assumptions, not a forecast)

Search, filter and export more FDAPulse records

Run instant live search with these filters Download free sample CSV

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

36 / 100 Predicate Speed & CAPA Advisory Opportunity Score

  • Fast 89-day review: this device is a strong predicate for similar products.
  • Posted 42 days ago.

What is the FDAPulse record for Anti-HCV Next (K262156): 510(k) cleared for Abbott Laboratories in Illinois?

Anti-HCV Next (K262156) by Abbott Laboratories was cleared on 2026-09-23 after 89 days of review.

How does Anti-HCV Next (K262156): 510(k) cleared for Abbott Laboratories compare to other Illinois FDAPulse records?

Its amount of 89 is below the median (29th percentile); smaller records often move faster and face less competition. It is 42 days old, still within a typical 45-day follow-up window. Its Predicate Speed & CAPA Advisory Opportunity Score of 36/100 is modest; treat it as background rather than a priority.

Anti-HCV Next (K262156) vs. top 3 peers

Related records

Recent FDA 510(k) clearances FDA 510(k) clearances and recalls: Microbiology devices

More Illinois public-record feeds

Grants to Illinois Artists and Arts Organizations Pulse in Illinois New Federal, Colorado, NYC & Chicago Lobbying Clients in Illinois Newly Medicare-Certified Hospices, Home Health Agencies & Dialysis Centers in Illinois New & Re-Approved E-Rate Service Providers (FCC Form 498 / SPIN) in Illinois Carrier Out-of-Service Alerts in Illinois Credit Union Quarterly Changes, Mergers & New Charters (NCUA Call Reports) in Illinois EPA Brownfields Award Tracker in Illinois Largest U.S. Greenhouse Gas Emitters by Company, Sector & State (EPA GHGRP) in Illinois

How to monitor Anti-HCV Next (K262156): 510(k) cleared for Abbott Laboratories and peer microbiology records

Get new FDAPulse records like Anti-HCV Next (K262156): 510(k) cleared for Abbott Laboratories by email (free, weekly)

We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.

Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.

See this week's digest

Get clearances and recalls like this every day

FDAPulse emails new 510(k) clearances and recalls for your specialties and competitors.

See plans

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

Data from the FDA openFDA API, which may lag official FDA databases. Informational only; not regulatory or legal advice.

Often used together

Or get the Healthcare Vendor Bundle for $14.99 one-time: Full CSV unlocks for group practices and FDA clearances/recalls.